Literature DB >> 34854916

Role of Rho GTPases in stem cell regulation.

Zheng Zhang1, Ming Liu2, Yi Zheng1.   

Abstract

The future of regenerative medicine relies on our understanding of stem cells which are essential for tissue/organ generation and regeneration to maintain and/or restore tissue homeostasis. Rho family GTPases are known regulators of a wide variety of cellular processes related to cytoskeletal dynamics, polarity and gene transcription. In the last decade, major new advances have been made in understanding the regulatory role and mechanism of Rho GTPases in self-renewal, differentiation, migration, and lineage specification in tissue-specific signaling mechanisms in various stem cell types to regulate embryonic development, adult tissue homeostasis, and tissue regeneration upon stress or damage. Importantly, implication of Rho GTPases and their upstream regulators or downstream effectors in the transformation, migration, invasion and tumorigenesis of diverse cancer stem cells highlights the potential of Rho GTPase targeting in cancer therapy. In this review, we discuss recent evidence of Rho GTPase signaling in the regulation of embryonic stem cells, multiple somatic stem cells, and cancer stem cells. We propose promising areas where Rho GTPase pathways may serve as useful targets for stem cell manipulation and related future therapies.
© 2021 The Author(s). Published by Portland Press Limited on behalf of the Biochemical Society.

Entities:  

Keywords:  Rho gtpases; differentiation; pluripotency; regenerative medicine; self-renewal; stem cell therapy

Mesh:

Substances:

Year:  2021        PMID: 34854916      PMCID: PMC9008577          DOI: 10.1042/BST20211071

Source DB:  PubMed          Journal:  Biochem Soc Trans        ISSN: 0300-5127            Impact factor:   5.407


  104 in total

1.  The cell polarity determinant CDC42 controls division symmetry to block leukemia cell differentiation.

Authors:  Benjamin Mizukawa; Eric O'Brien; Daniel C Moreira; Mark Wunderlich; Cindy L Hochstetler; Xin Duan; Wei Liu; Emily Orr; H Leighton Grimes; James C Mulloy; Yi Zheng
Journal:  Blood       Date:  2017-08-04       Impact factor: 22.113

2.  Small Rho GTPase Rac1 determines human epidermal stem cell fate in vitro.

Authors:  Linlin Chai; Chuan Cao; Sheng Bi; Xia Dai; Lu Gan; Rui Guo; Shirong Li
Journal:  Int J Mol Med       Date:  2010-05       Impact factor: 4.101

3.  Inhibition of the Rho signaling pathway improves neurite outgrowth and neuronal differentiation of mouse neural stem cells.

Authors:  Haigang Gu; Shan Ping Yu; Claire-Anne Gutekunst; Robert E Gross; Ling Wei
Journal:  Int J Physiol Pathophysiol Pharmacol       Date:  2013-03-08

4.  Rho/Rho-associated protein kinase signaling pathway-mediated downregulation of runt-related transcription factor 2 expression promotes the differentiation of dental pulp stem cells into odontoblasts.

Authors:  Xiaoqing Huang; Xiaoling Chen; Hongbai Chen; Dongwei Xu; Chen Lin; Bin Peng
Journal:  Exp Ther Med       Date:  2018-03-21       Impact factor: 2.447

5.  Rho-Associated Protein Kinase (ROCK) Inhibitors Inhibit Survivin Expression and Sensitize Pancreatic Cancer Stem Cells to Gemcitabine.

Authors:  Hiroyuki Takeda; Masashi Okada; Shuhei Suzuki; Kenta Kuramoto; Hirotsugu Sakaki; Hikaru Watarai; Tomomi Sanomachi; Shizuka Seino; Takashi Yoshioka; Chifumi Kitanaka
Journal:  Anticancer Res       Date:  2016-12       Impact factor: 2.480

6.  Vav1 Regulates Mesenchymal Stem Cell Differentiation Decision Between Adipocyte and Chondrocyte via Sirt1.

Authors:  Peng Qu; Lizhen Wang; Yongfen Min; Lois McKennett; Jonathan R Keller; P Charles Lin
Journal:  Stem Cells       Date:  2016-04-21       Impact factor: 6.277

7.  A canonical to non-canonical Wnt signalling switch in haematopoietic stem-cell ageing.

Authors:  Maria Carolina Florian; Kalpana J Nattamai; Karin Dörr; Gina Marka; Bettina Uberle; Virag Vas; Christina Eckl; Immanuel Andrä; Matthias Schiemann; Robert A J Oostendorp; Karin Scharffetter-Kochanek; Hans Armin Kestler; Yi Zheng; Hartmut Geiger
Journal:  Nature       Date:  2013-10-20       Impact factor: 49.962

8.  PAR1 participates in the ability of multidrug resistance and tumorigenesis by controlling Hippo-YAP pathway.

Authors:  Daisuke Fujimoto; Yuki Ueda; Yasuo Hirono; Takanori Goi; Akio Yamaguchi
Journal:  Oncotarget       Date:  2015-10-27

9.  RhoA determines lineage fate of mesenchymal stem cells by modulating CTGF-VEGF complex in extracellular matrix.

Authors:  Changjun Li; Gehua Zhen; Yu Chai; Liang Xie; Janet L Crane; Emily Farber; Charles R Farber; Xianghang Luo; Peisong Gao; Xu Cao; Mei Wan
Journal:  Nat Commun       Date:  2016-04-29       Impact factor: 14.919

10.  Hematopoietic defects in response to reduced Arhgap21.

Authors:  Juliana Xavier-Ferrucio; Lauremília Ricon; Karla Vieira; Ana Leda Longhini; Mariana Lazarini; Carolina Louzão Bigarella; Gilberto Franchi; Diane S Krause; Sara T O Saad
Journal:  Stem Cell Res       Date:  2017-11-23       Impact factor: 2.020

View more
  2 in total

Review 1.  Roles of Podoplanin in Malignant Progression of Tumor.

Authors:  Hiroyuki Suzuki; Mika K Kaneko; Yukinari Kato
Journal:  Cells       Date:  2022-02-07       Impact factor: 6.600

Review 2.  Mutant p53, the Mevalonate Pathway and the Tumor Microenvironment Regulate Tumor Response to Statin Therapy.

Authors:  Madison Pereira; Kathy Matuszewska; Alice Glogova; Jim Petrik
Journal:  Cancers (Basel)       Date:  2022-07-19       Impact factor: 6.575

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.